Does LORAZEPAM Cause Excessive granulation tissue? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Excessive granulation tissue have been filed in association with LORAZEPAM (Lorazepam). This represents 0.0% of all adverse event reports for LORAZEPAM.
5
Reports of Excessive granulation tissue with LORAZEPAM
0.0%
of all LORAZEPAM reports
0
Deaths
5
Hospitalizations
How Dangerous Is Excessive granulation tissue From LORAZEPAM?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Excessive granulation tissue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Excessive granulation tissue?
CARBIDOPA\LEVODOPA (117)
ADALIMUMAB (38)
BACLOFEN (31)
ZOLEDRONIC ACID (29)
ZOMETA (27)
AREDIA (21)
METHOTREXATE (19)
RITUXIMAB (13)
BECAPLERMIN (11)
PAMIDRONATE (11)
Which LORAZEPAM Alternatives Have Lower Excessive granulation tissue Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN